loader

Immix Biopharma

NCM:IMMX
Immix Biopharma Inc is a clinical-stage biopharmaceutical company developing Tissue-Specific Therapeutics in oncology and inflammation.
Featured Articles and Interviews
Press Releases

Nancy T. Chang, Proven Biotechnology Leader, Joins Immix Biopharma Board of Directors

Immix Biopharma Announces Strategic Investment by Houston based Goose Capital, led by founding member Dr. Nancy T. Chang

Immix Biopharma to Present at the Stifel 2025 Healthcare Conference

Immix Biopharma Inc is a clinical-stage biopharmaceutical company developing Tissue-Specific Therapeutics in oncology and inflammation.

Interactive Chart

×